Results 121 to 130 of about 37,370 (230)

MUC16/CA125 in cancer: new advances

Clinica Chimica Acta
MUC16/CA125 is a common diagnostic marker for many types of cancer. However, due to the widespread expression of MUC16 in cancer, its specificity and sensitivity as a target are poor, which severely limits its clinical application. In recent years, various studies have shown that the clinical application potential of MUC16/CA125 has been greatly ...
Xin-Yu, Zhang, Lian-Lian, Hong, Zhi-Qiang, Ling   +2 more
openaire   +2 more sources

Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age

, 2013
Objective: Evaluating the presence of possible malignant disease in women with ovarian masses relies on medical imaging and serum marker findings. This study considers the role of serum Human Epididymal Protein 4 (HE4) antigen in combination with other ...
Obermair, Andreas, Bowtell, David, Kondalsamy-Chennakesavan, Srinivas, Hackethal, Andreas   +3 more
core   +1 more source

Livello sierico del CA125 prima dello sviluppo del cancro dell’ovaio [PDF]

, 2008
Background: Poco si conosce della storia naturale del cancro dell’ovaio, riguardo alla modificazione del livello sierico del CA125. Metodi: Il Sizuoka Cohort Study on Ovarian Cancer Screening (SCSOCS) Trial contiene circa 100.000 dati sul marker tumorale
Yamada, Y., Ooi, H., Kawaguchi, R., Kanayama, S., Sakata, M., Terao, T., Kobayashi, H., Sumimoto, K.   +7 more
core  

CA125 effects on humoral immunosuppression

Aging, 2017
Kline, J. Bradford, Nicolaides, Nicholas C.   +1 more
openaire   +2 more sources

Evaluation of angiopoietin-like protein 4 levels in patients with endometriosis. [PDF]

J Turk Ger Gynecol Assoc
Eşkin Tanrıverdi MD, Erol Koç EM.
europepmc   +1 more source

Clinical Value of an LDH-CA125-NLR Panel for Diagnosis, Platinum Resistance, and Prognostic Assessment in Epithelial Ovarian Cancer. [PDF]

Curr Oncol
Xu S, Guo J, Zhao Z, Zhai Y, Liu Y, Li H.   +5 more
europepmc   +1 more source

Preoperative serum HE4 combined with CA125 testing for predicting the risk of suboptimal cytoreduction in advanced epithelial ovarian cancer. [PDF]

Front Oncol
Zhou C, Wu Y, Wang J, Zheng F.
europepmc   +1 more source

Evolution of CA 125 and NT-proBNP in stable patients with Fontan circulation: longitudinal analysis with sex perspective. [PDF]

Int J Cardiol Congenit Heart Dis
Gil Molina M, Buendía Fuentes F, Calvo Asensio M, Arnau Vives MÁ, Rodríguez Serrano M, Aguero J, Osa Sáez A, Martínez Dolz L, Rueda Soriano J.   +8 more
europepmc   +1 more source

Preoperative CA125 and metabolic factors associated with high-risk pathology in endometrial cancer. [PDF]

Oncol Lett
Wang Y, Yan Y, Sun W, Gao Y, Qi B, Li X, Liu S, Liu S.   +7 more
europepmc   +1 more source

Clinicopathological and preoperative biomarkers associated with recurrence after primary surgical treatment for endometrial cancer. [PDF]

Front Oncol
Liu YH, Wei B.
europepmc   +1 more source